Cell Therapies for Life-Threatening Diseases
The Unmet Needs
LyGenesis’s cell therapies are targeted at some of the largest unmet needs in medicine, from Type 1 diabetes to end stage liver and renal disease.
- LiverEnd Stage Liver DiseasePhase 2A
- ThymusAgingPOC Completed
- KidneysEnd Stage Renal DiseasePOC Completed
- PancreasType 1 DiabetesPOC Completed
- LiverInborn Errors of MetabolismDiscovery
LyGenesis, Inc. is a clinical-stage cell therapy company that transforms a patient’s lymph nodes into bioreactors capable of growing functioning ectopic organs.